The future of pharmaceutical supply chains isn’t just about adopting new technology — it’s about mastering the art of risk planning, quality control and proactive problem-solving. In part 2 of our Orchestrating Outcomes for Logistics interview series, Dan Bell, SVP of Innovation and Strategic Operations at Marken, highlights how building resilience into every link of the supply chain drives precision, progress and patient-centric innovation.  

Bell dives deeper into challenges and opportunities advancing digital transformation in pharma logistics, Marken’s customized service offerings, and the critical IT investments supporting these operations. He discusses the importance of end-to-end visibility and accuracy in logistics, and how data and KPIs help clients address issues in real time.

Explore how Marken is driving operational excellenceand patient-centric precision throughout the pharmaceutical supply chain from clinical to commercial.